[User satisfaction with telephonic consultations carried out during the COVID-19 pandemic.] 2021

Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
Hospital San Juan de Dios del Aljarafe. Bormujos. Sevilla. España.

OBJECTIVE To face the COVID-19 pandemic, our intensive care and hospitalization units were expanded, surgical activity was limited to urgent and non-delayed procedures and teleconsultations were increased in order to minimize face-to-face consultations. The objective of this work was to learn users' satisfaction with teleconsultations performed during the pandemic as well as its benefits, applications and areas for improvement. METHODS Cross-sectional study through a questionnaire with 26 closed questions and 5 open ones, grouped in 9 dimensions: patient characteristics; the query; treatment; utility; resolution; security; satisfaction; face-to-face modality and opportunities for improvement. Necessary sample size: 307 (confidence: 95%; error: 3%; expected satisfaction: 92%). Definitive sample: 352. Stratified random sampling by specialty. Period: March 16th-May 25th 2020. The statistical analysis was done with the statistical program SPSS vs.27.0. 95% confidence intervals were calculated.Statistical significance was established at p<0.05. RESULTS Patient profile: age 54 (SD: 18.6) years; 213 (60.5%) women. Calls made by doctors (298; 84.7%) and nurses (15; 4.3%); 342 (97.2%) attended at home. Reasons: follow-up (223; 63.4%); first consultation (45; 12.8%); result's report (23; 6.5%) and manage an appointment (50; 14.2%). 29 (8.62%) were directed to another center. 335 (95.44%; 95% CI: 93.26%-97.62%) patients were satisfied and 309 (91.96%; 95% CI: 89.06%-94.87%) would recommend them. 351 (99.72%; 95% CI: 99.16%-99.99%) felt they were treated with kindness; 336 (95.96%; 95% CI: 93.81%-98.11%) considered sufficient care; 309 (95.96%; 95% CI: 93.81%-98.11%) were able to solve doubts; 311 (96.58%; 95% CI: 94.60%-98.57%) calmed down; for 245 (69.6%; 95% CI: 65.98%-74.67%) it was as useful as the face-to-face session; equally safe (240; 69.57%; 95% CI: 64.71%-74.42%) and beneficial (338; 96.02%; 95% CI: 94.25%-98.26%). CONCLUSIONS The high satisfaction expressed by users, the benefits verified and the high resolution of the teleconsultations, makes us consider expanding these services after the pandemic.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
January 2022, The British journal of cardiology,
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
April 2021, The British journal of oral & maxillofacial surgery,
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
September 2021, Annals of the Royal College of Surgeons of England,
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
July 2020, Healthcare (Basel, Switzerland),
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
June 2020, Journal francais d'ophtalmologie,
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
February 2023, Minerva surgery,
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
January 2021, Health marketing quarterly,
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
April 2022, Workplace health & safety,
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
February 2024, Atencion primaria,
Victoria Ruiz-Romero, and Modesto Martínez-Pillado, and Yolanda Torres-Domínguez, and Dolores Acón-Royo, and Antonio De Toro-Salas, and Fernando Cruz-Villalón, and Adriana Rivera-Sequeiros
March 2023, Internet interventions,
Copied contents to your clipboard!